Although prior work in ER + breast cancer patients did not identify an association between pre-treatment TDLU involution and breast cancer-specific survival [25], additional work is warranted to elucidate the relationship between TDLU measures and survival across breast cancer molecular subtypes and racial and ethnic population groups. Here, ESR1 is linked to breast carcinoma.